GlassScriptPhysician profile
Abdullah M Omari
NPI 1386763928
$6,155.51
in general payments reported to CMS, 2019-2025
11 companies · $1,227 in 2025
The $1,227 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $914 · 2020: $156 · 2021: $322 · 2022: $2,342 · 2023: $529 · 2024: $665 · 2025: $1,227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,623 · Travel and Lodging: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,623.09 |
| Travel and Lodging | $798.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,753.32 | 2019-2025 | Mako, Accolade, X3 |
| Zimmer Biomet Holdings, INC. | $359.99 | 2020-2024 | Persona, Oss Orthopedic Salvage System |
| My01 INC. | $287.56 | 2024 | My01 Continuous Compartmental Pressure Monitor |
| Depuy Synthes Sales INC. | $215.61 | 2019-2021 | |
| Smith+Nephew, INC. | $146.43 | 2023 | Real Intelligence, Journey II |
| Pharmacosmos Therapeutics INC. | $124.23 | 2021 | |
| Janssen Pharmaceuticals, INC | $89.53 | 2024 | Xarelto |
| Kinamed, INC. | $71.08 | 2023 | |
| Ethicon US, LLC | $66.28 | 2024-2025 | Harmonic, Enseal, Megadyne |
| Convatec INC. | $27.05 | 2023 | |
| Linvatec Corporation | $14.43 | 2024 | Hall Power |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdullah Omari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.